Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001975 · ClinicalTrials.gov registry record
Study of Skin Tumors in Tuberous Sclerosis
A clinical trial of Tuberous Sclerosis, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT00001975: Recruiting study of Tuberous Sclerosis, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00001975 is a study of Tuberous Sclerosis that is actively recruiting participants, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 400 participants, below the 1,805-participant average among 6 other Tuberous Sclerosis trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001975, a study of Tuberous Sclerosis, is actively recruiting participants, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Tuberous sclerosis is a rare, hereditary disease in which patients develop multiple tumors. Although not cancerous, the tumors can affect various organs, including the heart, lungs, kidneys, skin, and central nervous system, with serious medical consequences. The severity of disease varies greatly among patients, from barely detectable to fatal. This study will investigate what causes skin tumors to develop in patients with this disease. Patients with tuberous sclerosis 18 years and older may enroll in this study. Participants will undergo a medical history and thorough skin examination by a dermatologist. Those with skin tumors will be asked to undergo biopsy (tissue removal) of up to eight lesions, under a local anesthetic, for research purposes. The biopsies will all be done the same day. The tissue samples will be used for: examination of genetic changes, measurement of certain proteins and other substances, and growing in culture to study the genetics of tuberous sclerosis. ...
Primary Outcome
natural history
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2000-01-26 |
What NCT00001975 shows while recruiting
NCT00001975 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,805-participant average among 6 other Tuberous Sclerosis trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Tuberous Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT00001975 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001975 about?
NCT00001975 is a clinical study titled "Study of Skin Tumors in Tuberous Sclerosis". Tuberous sclerosis is a rare, hereditary disease in which patients develop multiple tumors. Although not cancerous, the tumors can affect various organs, including the heart, lungs, kidneys, skin, and central nervous system, with serious medical consequences. The severity of disease varies greatly a...
What is the current status of trial NCT00001975?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2000-01-26.
What conditions does trial NCT00001975 study?
This clinical trial studies the following conditions: Tuberous Sclerosis.
Who is sponsoring clinical trial NCT00001975?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001975 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tuberous Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
RECRUITING · NA
-
TSC Biosample Repository and Natural History Database
RECRUITING
-
Role of Genetic Factors in the Development of Lung Disease
RECRUITING
-
Study of the Disease Process of Lymphangioleiomyomatosis
RECRUITING
-
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
ACTIVE NOT RECRUITING
-
Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI